BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 19683045)

  • 1. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique issue in the standardization of Chinese materia medica: processing.
    Zhao Z; Liang Z; Chan K; Lu G; Lee EL; Chen H; Li L
    Planta Med; 2010 Dec; 76(17):1975-86. PubMed ID: 21049396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica.
    Xie PS; Leung AY
    J Chromatogr A; 2009 Mar; 1216(11):1933-40. PubMed ID: 18757061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination system for prediction of Chinese Materia Medica properties.
    Long W; Liu P; Xiang J; Pi X; Zhang J; Zou Z
    Comput Methods Programs Biomed; 2011 Mar; 101(3):253-64. PubMed ID: 21315471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk?
    Singhuber J; Zhu M; Prinz S; Kopp B
    J Ethnopharmacol; 2009 Oct; 126(1):18-30. PubMed ID: 19651200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classification and application of toxic Chinese materia medica.
    Liu X; Wang Q; Song G; Zhang G; Ye Z; Williamson EM
    Phytother Res; 2014 Mar; 28(3):334-47. PubMed ID: 23722570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of mid-infrared spectroscopy in the quality control of traditional Chinese medicines.
    Sun S; Chen J; Zhou Q; Lu G; Chan K
    Planta Med; 2010 Dec; 76(17):1987-96. PubMed ID: 21049394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
    Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current situation of toxicity classification of Chinese materia medica and its research thoughts].
    Sun W; Hou X; Wang B; Zhu Y; Zhang S; Chang H; Sun J
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2199-201. PubMed ID: 23189717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on combination components and effectiveness of Chinese traditional herbal formulas].
    Wang J; Guo LL; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):5-9. PubMed ID: 16548156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese medicinal materials and their interface with Western medical concepts.
    Chan K
    J Ethnopharmacol; 2005 Jan; 96(1-2):1-18. PubMed ID: 15588645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional toxicity documentation of Chinese Materia Medica--an overview.
    Leung AY
    Toxicol Pathol; 2006; 34(4):319-26. PubMed ID: 16787890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authentication is fundamental for standardization of Chinese medicines.
    Zhao Z; Hu Y; Liang Z; Yuen JP; Jiang Z; Leung KS
    Planta Med; 2006 Aug; 72(10):865-74. PubMed ID: 16902852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles for molecular identification of traditional Chinese materia medica using DNA barcoding].
    Chen SL; Yao H; Han JP; Xin TY; Pang XH; Shi LC; Luo K; Song JY; Hou DY; Shi SM; Qian ZZ
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):141-8. PubMed ID: 23672031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current global status of Chinese materia medica.
    Liu X; Zou J; Sheng Z; Su G; Chen S
    Phytother Res; 2009 Oct; 23(10):1493-5. PubMed ID: 19787664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survey of investigations on Daodi Chinese medicinal materials in China since 1980s].
    Xiao X; Chen S; Huang L; Xiao P
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):519-23. PubMed ID: 19526774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of six Aconitum alkaloids in proprietary Chinese medicines by high-performance liquid chromatography.
    Xie Y; Jiang ZH; Zhou H; Xu HX; Liu L
    J Chromatogr A; 2005 Nov; 1093(1-2):195-203. PubMed ID: 16233884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
    Kim EJ; Chen Y; Huang JQ; Li KM; Razmovski-Naumovski V; Poon J; Chan K; Roufogalis BD; McLachlan AJ; Mo SL; Yang D; Yao M; Liu Z; Liu J; Li GQ
    J Ethnopharmacol; 2013 Mar; 146(1):40-61. PubMed ID: 23286904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.
    Williamson EM; Lorenc A; Booker A; Robinson N
    J Ethnopharmacol; 2013 Sep; 149(2):453-62. PubMed ID: 23832055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.